IDIBELL researcher Josep Maria Aran and his research group will receive 100,000 euros from the aid Product from the AGAUR agency of the Generalitat de Catalunya. They will study two molecules that act on the immune system as possible treatments for autoimmune diseases.
The interaction of these two receptors leads to the inhibition of the dopaminergic pathway, which in this disorder is abnormally active. This discovery opens the door to the design of new drugs for the treatment of schizophrenia that acts on this interaction.
The project aims to create online courses that help pre-doctoral researchers to acquire transversal skills for the future of their careers.
Although polyphenols have shown anticarcinogenic activity in previous in vitro studies, the epidemiological study led by IDIBELL and the ICO has found no association between their concentration in blood and thyroid cancer.
A group of researchers from IDIBELL, CIBERSAM and the Hospital de Bellvitge have identified changes in the connection between the frontal cortex and subcortical regions in girls and boys with mild symptoms of obsessive-compulsive disorder (OCD).
Results could inform discussions on food packaging labels across Europe, say researchers. The study has the participation of Antonio Agudo and has been published in the journal The BMJ.
Until now, TP53 mutations had been associated with a syndrome with a high risk of developing cancer that did not include colorectal tumors.
This tool is able to identify single-person neurodegeneration before the symptom’s appearance, which could significate a more effective and personalized medicine.
A study has evaluated the efficacy and safety of the combination of 3 cycles of chemotherapy with immunotherapy before surgery, in 51 patients with locally advanced lung cancer, followed by one year of treatment with immunotherapy.
This study has used a new technique called ‘T-cell receptor (TCR) immuno-sequencing’, which allows us to obtain both the number of T lymphocytes that infiltrate the tumor and their clonality index.
